Psychiatry and Clinical Neurosciences · 2011 · 14 citations · 6 references
MedicineCritical Care NursingPharmacotherapyCritical Care PharmacologyCritical Care PharmacotherapyNeurocritical CareDelirium AssessmentDelirium CareDelirium In Critical IllnessDelirium ManagementDelirium PharmacotherapyNeurocritical Care PharmacotherapyDelirium Management PharmacotherapyPharmacologic Delirium ManagementPharmacologic Delirium Treatment
The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side-effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.
6
The memorial delirium assessment scale
William Breitbart, Barry Rosenfeld, Andrew Roth et al. · Journal of Pain and Symptom Management · 1997 · 855 citations
Olanzapine vs haloperidol: treating delirium in a critical care setting
Yoanna K. Skrobik, Nicolas Bergeron, Marc Dumont et al. · Intensive Care Medicine · 2003 · 448 citations · Full text
An Empirical Study of Delirium Subtypes
Benjamin Liptzin, Sue E. Levkoff · The British Journal of Psychiatry · 1992 · 402 citations